30 drugs are monitored

< br / > < br / > according to the information gathered from Nanyang Pharmaceutical Co., Ltd., recently, Wuhan Pharmaceutical Machinery Co., Ltdissued the notice on soliciting public opinions on the list of drugs for key monitoring and rational use in Wuhan in 2020 (hereinafter referred to as the notice)< br / > according to Cyprian, there are 30 varieties in the list of drugs for key monitoring and rational use of drugs in Wuhan in 2020, in addition to 20 varieties in the list of drugs for national key monitoring, In addition, 10 varieties of Guhong injection, Shenxiong Injection, Luffa polypeptide injection, placenta polypeptide injection, safflower yellow pigment injection, alanyl glutamine, riboflavin sodium phosphate, invert sugar and xylitol were added< br / > among them, five varieties of Guhong injection, Shenxiong Injection, Luffa polypeptide injection, placenta polypeptide injection and safflower yellow pigment injection are also included in the "first batch of key monitoring and rational drug use catalogue in Hubei Province"< br / > according to the notice, in order to promote the key monitoring of rational drug price negotiation in Wuhan, guarantee the clinical drug demand, control the unreasonable growth of medical expenses and the virtual high price of drugs, Wuhan joint procurement plans to list such varieties as alanyl glutamine in the list of key monitoring rational drugs in Wuhan medical institutions, With the first batch of key monitoring drugs in Hubei Province in the list of varieties of rational use of drugs to implement bargaining procurement< br / > that is to say, the varieties that enter the list of key monitored drugs in Wuhan in 2020 may face bargaining purchaseIn fact, this is not the first time that the key monitoring varieties have been purchased in the form of price negotiation< br / > on August 30 last year, Qinghai Province issued the notice on bidding for centralized procurement of drugs in 2019 in Qinghai Province, which announced to carry out volume procurement for key monitored varieties and basic infusion varieties< br / > the purchased varieties include monosialotetrahexosylganglioside sodium injection, oxiracetam capsule, cerebrosine and carnosine injection, sodium phosphocreatine for injection, deproteinized calf serum injection, alprostadil injection, troxerutin cerebroprotein hydrolysate injection, compound coenzyme for injection, danshenchuangongzine injection, invert sugar electrolyte injection, thymopentin injection Edaravone injection, vinpocetine injection and cinepazide maleate injection< br / > it is worth noting that the notice of Wuhan city is mainly aimed at medical institutions above the second level in Wuhan cityAccording to the questionnaire, on the basis of the existing 30 varieties, the notified medical institutions have the right to add or delete varieties, which seems to be understood that the scope of varieties involved in the final key monitoring catalogue of Wuhan city is likely to be further expanded< br / > according to the observation of cypress blue, during the period after the outbreak of new crown, the policy trend of key monitored varieties increased significantly< br / > on July 1, 2019, the national health and Health Commission officially released the first batch of national key monitoring and rational use drugs catalogue (chemical and biological products)< br / > according to the key monitoring varieties, the national health and Health Commission requires that all medical institutions should establish the management system of key monitoring and rational use of drugs, and strengthen the whole process management of the clinical application of drugs in the catalogIn order to ensure rational use of drugs, measures such as ranking notification, rectification within a time limit and clearing out the drug supply catalogue of the agency shall be taken for the varieties with prominent unreasonable use of drugs< br / > on August 20, 2019, the state health insurance bureau issued the notice of the Ministry of human resources and social security of the State Health Insurance Bureau on printing and distributing the catalogue of drugs for national basic medical insurance, work injury insurance and maternity insurance, which pointed out that the class B drugs increased according to regulations in the original provincial drug catalogue should be gradually digested within three yearsIn the process of digestion, provinces should give priority to adjusting the payment scope of drugs included in the national key monitoring scope < br / > on November 15, 2019, the State Council issued the notice of the leading group of the State Council on deepening the reform of the medical and health system on further promoting the experience of deepening the reform of the medical and health system in Fujian Province and Sanming City, which further requires that all provinces establish a comprehensive monitoring mechanism for key drugs by the end of December 2020, that is, this year < br / > on June 9, the national health and Health Commission issued the notice on the collection of performance appraisal data of public hospitals in 2019 According to the requirements of the operation manual for performance appraisal of national level II public hospitals (2020 Edition), the national level II hospitals should make statistics on the "proportion of income from key monitoring drugs", and the use of key monitoring drugs has become an important indicator of public hospital appraisal < br / > recently, the notice of Hebei health and Health Commission on deepening medical reform also requires strengthening the monitoring of key drugs - medical institutions should establish and improve the monitoring, evaluation, abnormal early warning system and key monitoring drug management system, We will strengthen the whole process management of drug selection, purchase, dispensing, use, monitoring, evaluation, prescription review and comment, which are mainly monitored by auxiliary and nutritional drugs < br / > in the second half of the new crown epidemic, the pressure of drug control intensified, and the relevant policies of focusing on drug monitoring may be further tightened or even strengthened